United States · FDA National Drug Code directory
Tacrolimus
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 55111-525_706bafff-d629-291c-5ce5-83d74a638860
- Product NDC
- 55111-525
- Form
- CAPSULE
- Composition / generic term
- Tacrolimus
- Labeler
- Dr. Reddy's Laboratories Limited
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20100514
- Source listing expiry
- 20261231
Source-listed ingredients
- TACROLIMUS — .5 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 1 BOTTLE in 1 CARTON (55111-525-01) / 100 CAPSULE in 1 BOTTLE · 55111-525-01
- 1 BOTTLE in 1 CARTON (55111-525-05) / 500 CAPSULE in 1 BOTTLE · 55111-525-05
- 1 BOTTLE in 1 CARTON (55111-525-30) / 30 CAPSULE in 1 BOTTLE · 55111-525-30
- 10 BLISTER PACK in 1 CARTON (55111-525-78) / 10 CAPSULE in 1 BLISTER PACK (55111-525-79) · 55111-525-78
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →